We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVE icon
12526
PUT
Dave Inc
DAVE
$4.27B
$8K ﹤0.01%
372
-3,853
-91% -$373K
ENVB icon
12527
CALL
Enveric Biosciences
ENVB
$6.18M
$8K ﹤0.01%
4
-20
-83% -$42.5K
JAGX icon
12528
PUT
Jaguar Health
JAGX
$4.5M
0
PAVS icon
12529
Paranovus Entertainment Technology
PAVS
$6.03M
0
PIIIW icon
12530
P3 Health Partners Inc Warrant
PIIIW
$153K
$8K ﹤0.01%
19,211
+768
+4% +$907
UBX
12531
PUT
DELISTED
Unity Biotechnology
UBX
$8K ﹤0.01%
1,340
-5,040
-79% -$42K
AMBR
12532
PUT
Amber International Holding Ltd
AMBR
$124M
$8K ﹤0.01%
1,120
-1,430
-56% -$11.8K
PIXY
12533
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$8K ﹤0.01%
+1
New +$13.8K
ASLN
12534
CALL
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$8K ﹤0.01%
+400
New +$8.87K
OPGN
12535
DELISTED
OpGen, Inc
OPGN
$8K ﹤0.01%
+75
New +$8.17K
HPX.WS
12536
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$8K ﹤0.01%
100,791
-734
-0.7% -$112
LGACW
12537
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$8K ﹤0.01%
31,400
-149,599
-83% -$57.1K
LCI
12538
PUT
DELISTED
Lannett Company, Inc.
LCI
$8K ﹤0.01%
3,325
-550
-14% -$1.37K
BIOR
12539
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$8K ﹤0.01%
47
-1,641
-97% -$346K
CLRMW
12540
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
$8K ﹤0.01%
68,387
-166,779
-71% -$29K
LOGC
12541
CALL
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$8K ﹤0.01%
21,500
+2,700
+14% +$1.37K
NAVB
12542
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$8K ﹤0.01%
11,200
-2,900
-21% -$2.46K
KIQ
12543
DELISTED
Kelso Technologies Inc.
KIQ
$8K ﹤0.01%
26,971
+13,622
+102% +$5.06K
SLAI
12544
PUT
DELISTED
SOLAI Ltd ADS
SLAI
$7K ﹤0.01%
+160
New +$20K
CPHI icon
12545
China Pharma Holdings
CPHI
$45.8M
$7K ﹤0.01%
+70
New +$9.37K
GOCO
12546
CALL
DELISTED
GoHealth
GOCO
$7K ﹤0.01%
773
-127
-14% -$1.48K
ICUCW
12547
SeaStar Medical Holding Corp Warrant
ICUCW
$339K
$7K ﹤0.01%
65,237
-201
-0.3% -$29
UXIN
12548
CALL
Uxin Ltd
UXIN
$260M
$7K ﹤0.01%
158
-37
-19% -$2.22K
DNA.WS
12549
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$7K ﹤0.01%
+12,491
New +$7.92K
MARK
12550
DELISTED
Remark Holdings, Inc.
MARK
$7K ﹤0.01%
1,680
-1,825
-52% -$9.72K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.